Please read the disclaimer and prospectus at www.bualuang.co.th/dr. For more information, please contact Bualuang Securities Public Company Limited at 0-2618-1111.

Reminder: Investing in Depositary Receipt (DR) is not equivalent to cash deposit. Investors should understand the product nature, conditions, risk and return from the prospectus and terms and conditions governing the rights obligations and responsibilities of DR Issuer and Holders, as well as seek for further advice from an investment consultant before investing. The prospectus and terms and conditions can be downloaded at www.sec.or.th and www.set.or.th.

The "S&P 500 Index" is a product of S&P Dow Jones Indices LLC or its affiliates (“SPDJI”), and has been licensed for use by Bualuang Securities Public Company Limited. Standard & Poor’s®, S&P® are registered trademarks of Standard & Poor’s Financial Services LLC (“S&P”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”); and these trademarks have been licensed for use by SPDJI and sublicensed for certain purposes by Bualuang Securities Public Company Limited. DR SP50001 is not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability for any errors, omissions, or interruptions of the S&P 500 Index.